Related Experiment Video
Updated: Jul 5, 2026

07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Bottlenecks in molecular testing for rare genetic diseases
1Genetic Diagnostic Network (GENDIA), Antwerp, Belgium. willemspatrick@skynet.be
Human Mutation
|April 17, 2008
Summary
Molecular diagnosis for rare genetic disorders remains slow and expensive, despite advances in genetic research. Addressing these bottlenecks is crucial to bridge the gap between genomic discovery and patient diagnosis.
Area of Science:
- Genetics
- Molecular Biology
- Medical Diagnostics
Background:
- Significant advancements in understanding genetic disease causes have occurred.
- Molecular diagnostic testing for rare genetic disorders faces substantial challenges.
- A gap exists between genomic research capabilities and practical diagnostic applications for patients.
Purpose of the Study:
- To discuss the current limitations and bottlenecks in molecular testing for rare genetic disorders.
- To highlight the challenges hindering accessible and reliable genetic diagnosis.
- To identify areas for improvement in the molecular diagnostic landscape.
Main Methods:
- Discussion of existing bottlenecks in molecular testing.
- Analysis of challenges in rare genetic disorder diagnosis.
- Review of the current state of molecular diagnostic services.
Main Results:
- Molecular diagnosis for rare genetic disorders is characterized by being slow, expensive, unreliable, insufficient, and poorly organized globally.
- The gap between genomic research progress and diagnostic accessibility persists.
- Significant obstacles impede timely and accurate genetic diagnoses for affected individuals and families.
Conclusions:
- Urgent improvements are needed to overcome the identified bottlenecks in molecular diagnostic testing.
- Enhanced organization and efficiency are required to make genetic diagnoses more accessible.
- Bridging the gap requires addressing the limitations in current diagnostic approaches for rare genetic diseases.

